Literature DB >> 5937675

Uric acid production with particular reference to the role of xanthine oxidase and its inhibition.

R W Watts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5937675      PMCID： PMC1900614     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  33 in total

1.  PSEUDOFEEDBACK INHIBITION OF PURINE SYNTHESIS BY 6-MERCAPTOPURINE RIBONUCLEOTIDE AND OTHER PURINE ANALOGUES.

Authors:  R J MCCOLLISTER; W R GILBERT; D M ASHTON; J B WYNGAARDEN
Journal:  J Biol Chem       Date:  1964-05       Impact factor: 5.157

2.  XANTHINURIA AND HEMOCHROMATOSIS.

Authors:  J H AYVAZIAN
Journal:  N Engl J Med       Date:  1964-01-02       Impact factor: 91.245

3.  THE RENAL EXCRETION OF OXYPURINES.

Authors:  S GOLDFINGER; J R KLINENBERG; J E SEEGMILLER
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808

4.  Augmentation of the incorporation of hypoxanthine into nucleic acids by the administration of an inhibitor of xanthine oxidase.

Authors:  R POMALES; S BIEBER; R FRIEDMAN; G H HITCHINGS
Journal:  Biochim Biophys Acta       Date:  1963-05-28

5.  Uric acid production in gout.

Authors:  J E SEEGMILLER; A I GRAYZEL; L LASTER; L LIDDLE
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

6.  The enzymic oxidation and assay of adenine.

Authors:  H KLENOW
Journal:  Biochem J       Date:  1952-01       Impact factor: 3.857

7.  Allopurinal and acute uric acid nephropathy.

Authors:  R W Watts; P J Watkins; J Q Matthias; D A Gibbs
Journal:  Br Med J       Date:  1966-01-22

8.  Specific action of adenine as a feedback inhibitor of purine biosynthesis.

Authors:  J S GOTS; J GOLDSTEIN
Journal:  Science       Date:  1959-09-11       Impact factor: 47.728

9.  The involvement of 5-phosphoribosylamine in the biosynthesis of glycinamide ribotide.

Authors:  D A GOLDTHWAIT; G R GREENBERG; R A PEABODY
Journal:  Biochim Biophys Acta       Date:  1955-09

10.  Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine).

Authors:  R W Watts; J E Watts; J E Seegmiller
Journal:  J Lab Clin Med       Date:  1965-10
View more
  7 in total

1.  Hyperuricaemia: some biochemical aspects.

Authors:  R W Watts
Journal:  Proc R Soc Med       Date:  1969-08

Review 2.  Molecular variation in relation to purine metabolism.

Authors:  R W Watts
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

3.  Gender, body mass index, and PPARγ polymorphism are good indicators in hyperuricemia prediction for Han Chinese.

Authors:  Ming-Fen Lee; Tsan-Hon Liou; Weu Wang; Wen-Harn Pan; Wei-Jei Lee; Chung-Tan Hsu; Suh-Fen Wu; Hsin-Hung Chen
Journal:  Genet Test Mol Biomarkers       Date:  2013-01

4.  Acute kidney injury observed during phase 1 clinical trials of a novel xanthine oxidase/URAT1 dual inhibitor PF-06743649.

Authors:  Pinky Dua; Rachel Gurrell; Simon Kirby; Maria Sudworth; Peter T Loudon
Journal:  Clin Rheumatol       Date:  2016-04-19       Impact factor: 2.980

5.  High plasma uric acid concentration: causes and consequences.

Authors:  Erick Prado de Oliveira; Roberto Carlos Burini
Journal:  Diabetol Metab Syndr       Date:  2012-04-04       Impact factor: 3.320

Review 6.  Physiology of Hyperuricemia and Urate-Lowering Treatments.

Authors:  Caroline L Benn; Pinky Dua; Rachel Gurrell; Peter Loudon; Andrew Pike; R Ian Storer; Ciara Vangjeli
Journal:  Front Med (Lausanne)       Date:  2018-05-31

7.  Human Mutations in SLC2A9 (Glut9) Affect Transport Capacity for Urate.

Authors:  Anne Ruiz; Ivan Gautschi; Laurent Schild; Olivier Bonny
Journal:  Front Physiol       Date:  2018-06-18       Impact factor: 4.566
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.